PCSK9 and polycystic ovary syndrome: In particular, Mondal et al. demonstrated that hyperandrogenemia and hyperhomocysteinemia, two common features in PCOS, share a PCSK9-LDLR-dependent mechanism that disrupts cholesterol homeostasis, leading to impaired lipid clearance and exacerbated dyslipidemia [10].